Senior Scientific Staff
Andrew Cherniack, PhD
Group Leader, Computational Biology
2010-
PhD, The Ohio State University
Phone|Email
My group at the Broad and Dana-Farber is involved in three different efforts:
1) Along with Dr. Rameen Beroukhim, we lead efforts to analyze copy number alterations and rearrangements for the National Cancer Institute’s Genomic Data Analysis Network (GDAN).
2) We provide computational biology support for new target discovery and biomarker development for cancer therapeutics projects at the Broad Institute.
3) We collaborate with physicians and scientists across Dana-Farber on research projects utilizing clinical targeted sequencing data.
Group Leader, Computational Biology
2010-
PhD, The Ohio State University
Phone|Email
My group at the Broad and Dana-Farber is involved in three different efforts:
1) Along with Dr. Rameen Beroukhim, we lead efforts to analyze copy number alterations and rearrangements for the National Cancer Institute’s Genomic Data Analysis Network (GDAN).
2) We provide computational biology support for new target discovery and biomarker development for cancer therapeutics projects at the Broad Institute.
3) We collaborate with physicians and scientists across Dana-Farber on research projects utilizing clinical targeted sequencing data.
Brian Golbourn, PhD
Research Scientist II
2022-
PhD, University of Toronto - Brain Tumor Research Center
My research focus is the development of biochemical and cellular-based assays to study interactions between protein and DNA that are essential to cancer cell survival. Outside of the lab I enjoy biking, fishing, and snowboarding.
Research Scientist II
2022-
PhD, University of Toronto - Brain Tumor Research Center
My research focus is the development of biochemical and cellular-based assays to study interactions between protein and DNA that are essential to cancer cell survival. Outside of the lab I enjoy biking, fishing, and snowboarding.
Jon Goldstein, PhD
Research Scientist II
2014-
PhD, University of Wisconsin - Madison
Phone|Email|LinkedIn
My focus is to understand the biochemical and cellular consequences of genomic alterations in cancer. My goal is to translate these findings into targeted therapeutic candidates.
Research Scientist II
2014-
PhD, University of Wisconsin - Madison
Phone|Email|LinkedIn
My focus is to understand the biochemical and cellular consequences of genomic alterations in cancer. My goal is to translate these findings into targeted therapeutic candidates.
Heidi Greulich, PhD
Senior Group Leader/Director, Cancer Therapeutic Projects
2004-
PhD, The Rockefeller University
Phone|Email|LinkedIn
My group studies therapeutic targets identified from cancer genomic data with the goal of developing new cancer treatments. Target classes include mutated receptor tyrosine kinases, epigenetic targets, and small molecules that cause complex formation between PDE3A and SLFN12, inducing death of cancer cells expressing elevated levels of these two proteins.
Senior Group Leader/Director, Cancer Therapeutic Projects
2004-
PhD, The Rockefeller University
Phone|Email|LinkedIn
My group studies therapeutic targets identified from cancer genomic data with the goal of developing new cancer treatments. Target classes include mutated receptor tyrosine kinases, epigenetic targets, and small molecules that cause complex formation between PDE3A and SLFN12, inducing death of cancer cells expressing elevated levels of these two proteins.
Jodi Hirschman, PhD
Research Program Manager
2019-
PhD, University of California, Davis
Email|LinkedIn
I am the Research Program Manager both for the Meyerson laboratory and for Grand Challenge OPTIMISTICC project. For the former, I help with the writing and submission of research proposals and other communications; for the OPTIMISTICC project, I coordinate communications and events for the 13-lab consortium, and assist with scientific strategy.
Research Program Manager
2019-
PhD, University of California, Davis
Email|LinkedIn
I am the Research Program Manager both for the Meyerson laboratory and for Grand Challenge OPTIMISTICC project. For the former, I help with the writing and submission of research proposals and other communications; for the OPTIMISTICC project, I coordinate communications and events for the 13-lab consortium, and assist with scientific strategy.
Kristyna Kotynkova, PhD
Research Scientist I
2022-
PhD, University College London (Francis Crick Institute)
I am studying the mechanism of novel cancer therapeutics that target tumor cells expressing high levels of PDE3A and SLFN12. Outside the lab, I enjoy hiking, birding and rock climbing.
Research Scientist I
2022-
PhD, University College London (Francis Crick Institute)
I am studying the mechanism of novel cancer therapeutics that target tumor cells expressing high levels of PDE3A and SLFN12. Outside the lab, I enjoy hiking, birding and rock climbing.
Yvonne Li, PhD, FACMG
PhD, University of British Columbia, Canada
I collaborate with DFCI oncologists to leverage Profile OncoPanel targeted panel sequencing data for genomic analysis and clinical correlation.
PhD, University of British Columbia, Canada
I collaborate with DFCI oncologists to leverage Profile OncoPanel targeted panel sequencing data for genomic analysis and clinical correlation.
Gizem Karsli Uzunbas, PhD
Research Scientists II
2019-
PhD, Rutgers University
Email|LinkedIn
My research goal is to develop new therapeutic approaches to treat lung cancers with mutations identified by tumor sequencing.
Research Scientists II
2019-
PhD, Rutgers University
Email|LinkedIn
My research goal is to develop new therapeutic approaches to treat lung cancers with mutations identified by tumor sequencing.
Junior Scientific Staff
Sawyer Andersen, B.S.
Research Associate
2022-
B.S., University of Massachusetts Amherst
I am working to understand the mechanisms of novel cancer therapeutics that target tumor cells expressing high levels of SLFN12.
Research Associate
2022-
B.S., University of Massachusetts Amherst
I am working to understand the mechanisms of novel cancer therapeutics that target tumor cells expressing high levels of SLFN12.
Katherine Cho, B.S.
Research Technician
2022-
B.S., Johns Hopkins University
I am interested in examining why U2AF1 S34F mutations are selected for in lung adenocarcinomas.
Research Technician
2022-
B.S., Johns Hopkins University
I am interested in examining why U2AF1 S34F mutations are selected for in lung adenocarcinomas.
Akansha Gupta, B.S.
Associate Computational Biologist
2022-
B.S., University of Wisconsin-Madison
My work focuses on performing genomic analyses to identify new targets for cancer therapeutics. Additionally, I analyze copy number alterations and rearrangements for projects with the National Cancer Institute's Genomic Data Analysis Network (GDAN).
Associate Computational Biologist
2022-
B.S., University of Wisconsin-Madison
My work focuses on performing genomic analyses to identify new targets for cancer therapeutics. Additionally, I analyze copy number alterations and rearrangements for projects with the National Cancer Institute's Genomic Data Analysis Network (GDAN).
Kevin Jiang, B.S.
Research Associate
2022-
B.S., University of California, Los Angeles
I am working on researching the influence of Fusobacterium on colorectal cancer and the tumor microenvironment.
Research Associate
2022-
B.S., University of California, Los Angeles
I am working on researching the influence of Fusobacterium on colorectal cancer and the tumor microenvironment.
Lior Kofman, B.S.
Associate Computational Biologist
2021-
B.S., Tufts University
I am currently working on determining the influence of the microbiome on outcomes of various cancers and analyzing clinical sequencing data.
Associate Computational Biologist
2021-
B.S., Tufts University
I am currently working on determining the influence of the microbiome on outcomes of various cancers and analyzing clinical sequencing data.
Quinn McVeigh, B.A.
Research Associate
2021-
B.A., Carleton College
My work aims to develop novel targeting approaches to lung cancer using targets identified from genomic analysis.
Research Associate
2021-
B.A., Carleton College
My work aims to develop novel targeting approaches to lung cancer using targets identified from genomic analysis.
Zarin Mohsenin, B.S.
Research Technician
2021-
B.S., Haverford College
I am interested in elucidating the function of the gene Cmtr2 and its role in lung cancer.
Research Technician
2021-
B.S., Haverford College
I am interested in elucidating the function of the gene Cmtr2 and its role in lung cancer.
Robert Shue, B.S.
Associate Computational Biologist
2022-
B.A., Colby College
I work with OncoPanel to find correlations between targeted sequencing data and clinical outcomes.
Associate Computational Biologist
2022-
B.A., Colby College
I work with OncoPanel to find correlations between targeted sequencing data and clinical outcomes.
Stephanie Tang, A.B.
Research Associate
2020-
A.B., Harvard College
I am interested in exploring the genetic underpinnings of cancer and translating these findings into potential therapies.
Research Associate
2020-
A.B., Harvard College
I am interested in exploring the genetic underpinnings of cancer and translating these findings into potential therapies.
Patrick Zhuang, B.A.
Research Technician
2021-
B.A., Williams College
I have a background in chemistry. I'm interested in developing novel therapeutic strategies to target innate immune signaling pathways that regulate cancer cell viability.
Research Technician
2021-
B.A., Williams College
I have a background in chemistry. I'm interested in developing novel therapeutic strategies to target innate immune signaling pathways that regulate cancer cell viability.